Full course description
Comprehensive Pharmacist Patient Assessment, Prescribing, and Billing for Oregon's Tobacco Cessation Implementation:
In Oregon, more than 6 out of 10 people who smoke cigarettes want to quit. Most people who smoke have attempted to quit in the past year. Smoking is the leading preventable cause of death and disease in Oregon, killing nearly 8,000 people every year. Pharmacists in Oregon will make an impact on Oregon’s tobacco cessation endeavors. During the novel coronavirus pandemic, cigarette smoking has been linked to increased risk of severe COVID-19, including hospitalization and death.
Oregon State University College of Pharmacy, in partnership with the OHA, has led the creation of this training, which exceeds all requirements set forth by the Oregon Board of Pharmacy for approved training for tobacco cessation prescribing. The course is uniquely designed to educate the Oregon pharmacist on assessing and prescribing tobacco cessation medications based solely upon the Oregon Board of Pharmacy’s Public Health and Pharmacy Formulary Advisory Committee guidelines. The training is authored by the subject matter experts who were engaged in advising the PHPFAC and OBOP to create the Tobacco Cessation Patient Intake Form and Tobacco Cessation Assessment and Treatment Care Pathway.
The Oregon Health Authority – Public Health Division (OHA-PHD) and the Health Promotion and Chronic Disease Prevention Section (HPCDP) are excited to partner with the Oregon State University College of Pharmacy to educate and train pharmacists to treat nicotine addiction.
Accreditation Council for Pharmacy Education Information:
This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Certificate of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules and 3) Completion of the program evaluation.
Activity Type: Application
Activity Release Date: 11/01/2020
Activity Expiration Date: 11/01/2023
Paige Clark, Director, Office of Continuing Education ACPE Accreditation
About the Certification:
The Oregon Health Promotion and Chronic Disease Prevention Section of the Oregon Health Authority (OHA) and Oregon State University (OSU) College of Pharmacy’s Office of Continuing Education have partnered to support pharmacist engagement in tobacco cessation efforts. These efforts focus on pharmacist-driven patient assessment and prescribing pursuant to a statewide protocol developed by PHPFAC and adopted by the Board. This partnership provides Oregon pharmacists with a state-specific Tobacco Cessation Patient Assessment and Prescribing for Pharmacists continuing education (CE) program. It outlines and guides the pharmacist through the processes of providing tobacco cessation services, including patient assessment and prescribing of smoking cessation products utilizing the statewide protocol. The program also includes county-specific patient referral resources to support the pharmacist in efficiently managing the required patient referral to the Oregon Tobacco Quit Line or other resources for support, such as tobacco cessation counseling
An NABP e-Profile ID must be provided to receive CPE credit, if you need help credentialing please contact the OSU College of Pharmacy.
If you have questions regarding the course content, please email OSU College of Pharmacy Office of Continuing Education.